Dr Sanjay Kumar Jain

Dr Sanjay Kumar Jain

Dr Sanjay Kumar Jain

MBBS, MD, MRCP(UK), FRCP(UK), FRCP(Glasgow)

Gastroenterology

31 yrs+

Indraprastha Apollo Hospitals, Sarita Vihar, Delhi-mathura Road, New Delhi - 110076

Hospital Experience After Post-Graduation:

  • Registrar 1981-1983 Department of Medicine/Gastroenterology LNJPN Hospital, Delhi, India
  • Senior Resident 1983-1991 Department of Medicine/Gastroenterology, Buraidah Central Hospital, Saudi Arabia
  • SHO 1992-1993 Department of Gastroenterology, Cardiology, Respiratory Medicine and Medicine for Elderly Countess of Chester Hospital, Chester .UK
  • Registrar 1993-1996 Department of Gastroenterology and Medicine for elderly at Hull Royal Infirmary, UK
  • Senior Consultant Dec 1996 Department of Gastroenterology and Sep 2012 Hepatology, Apollo Hospitals, New Delhi, India
  • Senior Consultant Nov 2012 Department of Gatsroenterogy and Hepatology, Nov 2015 Moolchand Medcity, Lajpat Nagar, Delhi
  • Senior Consultant 27thNov 2015 Department Of Gastroenterology and Hepatology 28th Feb 2017   PSRI Hospital, Sheikh Sarai2, New Delhi
  • Senior Consultant   March 2017 Department of Gastroenterology and Hepatology Onwards.Indraprastha Apollo Hospitals, new Delhi

Clinical and Endoscopy Experience

Have seen 32000 new Gastroenterology patients in OPD in last approximately 20 years since my return to India in 1996 with a detailed data base of all these patients. This includes patients not only from India but also a good number of International patients. Average number of new and follow up patients seen in clinic have been approximately 400 to 500 per month.

Have looked after various Gastrointestinal Emergencies referred to tertiary care centre including GI bleeds, Acute Pancreatitis and Hepatic encephalopathy etc. Have been routinely involved in care of Gastro-intestinal and Hepatology indoor patients.

Have looked after various Gastrointestinal Emergencies referred to tertiary care centre including GI bleeds, Acute Pancreatitis and Hepatic encephalopathy etc. Have been routinely involved in care of Gastro-intestinal and Hepatology indoor patients.

Have been actively involved in Liver Transplant Program.

Have rich experience in both diagnostic and therapeutic UGI Endoscopy, Colonoscopy, ERCP,etc. I have been performing approximately 1500-2000 diagnostic and therapeutic Endoscopy procedures per year. I have also been trained for Fibroscan of liver . I have been Department and Endoscopy Coordinator for many years.

Research Experience

Presented research paper entitled ‘Aetiopathogenesis of Ulcerative Colitis- Role of Appendicectomy’ at British Society of Gastroenterology, UK 1996

Conducting international multicenter research trial ‘ A multicenter, Prospective, Observational, Non Interventional Cohort Study Evaluating on – Treatment Predictors of response in subjects with HBeAg positive or HBeAg negative Chronic Hepatitis B receiving Therapy with Pegasys(Peginterferon alfa 2a 40 KD) sponsored by Roche.

Participating in national multicentre study ‘Alcoholic Liver Disease – Evidence Development Program’ to study liver disease in India by Indigene Lifesystems Ltd.

Teaching Experience

  • Have been teaching DNB ( Gastro) students over last 8 years at Apollo hospital Delhi since the start of DNB Program.
  • Have trained both national and international students in diagnostic and therapeutic Endoscopic procedures.
  • Have been teaching both under-graduate and post graduate students since 1981.
  • Indian Society of Gastroenterology
  • Indian National Association for Study of Liver
  • Society of GI Endoscopy of India

Research and Publications

  • Presented research paper entitled ‘Aetiopathogenesis of Ulcerative Colitis- Role of Appendicectomy’ at British Society of Gastroenterology, UK 1996
  • Conducting international multicenter research trial ‘ A multicenter, Prospective, Observational, Non Interventional Cohort Study Evaluating on – Treatment Predictors of response in subjects with HBeAg positive or HBeAg negative Chronic Hepatitis B receiving Therapy with Pegasys(Peginterferon alfa 2a 40 KD) sponsored by Roche.
  • Participating in national multicentre study ‘Alcoholic Liver Disease – Evidence Development Program’ to study liver disease in India by Indigene Lifesystems Ltd.
Book ProHealth Book Appointment

Request A Call Back

Close